Keynote speakers at the cell signaling meeting in Luxembourg have provided chapters on hypoxia signal transduction, phosphoserine/threonine-binding domains, targeting of polycomb repressive complexes, conserved signaling mechanisms in innate immunity, and signal transduction by stress-activated MAP kinases. Other topics included among these reports on recent research are receptor signaling, protein kinase cascades as therapeutic targets, cell death in cancer, inflammation-specific signaling, cell signaling pathways leading to regulated chromatin modifications, and transcriptional control.
The chapters have been published in four volumes (Part A to D), offering a comprehensive overview about this exciting topic.
This fourth volume focuses on inflammatory signaling pathways and the role of signaling pathways in neuropathological conditions including depression, schizophrenia, Alzheimer's disease, and other senile dementias.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member
"synopsis" may belong to another edition of this title.
Marc Diederich is the editor of Signal Transduction Pathways, Part D: Inflammatory Signaling Pathways and Neuropathology, Volume 1096, published by Wiley.
This fouth volume to emerge from the cell signaling meeting in Luxembourg (see Part A, Part B, and Part C) focuses on the therapeutic potential for targeting cell signaling mechanisms with particular attention to cancer therapies and inflammatory signaling pathways as well as immunomodulation.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.
This fouth volume to emerge from the cell signaling meeting in Luxembourg (see Part A, Part B, and Part C) focuses on the therapeutic potential for targeting cell signaling mechanisms with particular attention to cancer therapies and inflammatory signaling pathways as well as immunomodulation.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.
"About this title" may belong to another edition of this title.
Seller: Research Ink, Takoma Park, MD, U.S.A.
Paperback. Condition: Very good. xxvii + 288 pp. Annals of the New York Academy of Sciences, volume1096. Rubber-stamped on half title page. book. Seller Inventory # 32343
Seller: Better World Books, Mishawaka, IN, U.S.A.
Condition: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. Seller Inventory # 2700545-6
Seller: Broad Street Books, Branchville, NJ, U.S.A.
Paperback. Condition: As New. Book is in excellent condition, text is unmarked and pages are tight. Seller Inventory # 30620